Rankings
▼
Calendar
LQDA
Liquidia Corporation
$3B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
+141.5% YoY
Gross Profit
$8M
85.4% margin
Operating Income
-$38M
-424.4% margin
Net Income
-$42M
-470.5% margin
EPS (Diluted)
$-0.49
QoQ Revenue Growth
+183.2%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$41M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$257M
Total Liabilities
$242M
Stockholders' Equity
$15M
Cash & Equivalents
$173M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$4M
+141.5%
Gross Profit
$8M
$2M
+248.3%
Operating Income
-$38M
-$27M
-37.9%
Net Income
-$42M
-$28M
-48.8%
Revenue Segments
Product
$7M
74%
Service
$2M
26%
← FY 2025
All Quarters
Q3 2025 →
LQDA Q2 2025 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena